WFG Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

WFG Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$12K	Sell	150 -1,100	-88%	-$78K	﹤0.01%	1096
2017 Q1	$87K	Sell	1,250 -300	-19%	-$20.1K	0.02%	514
2016 Q4	$92K	Sell	1,550 -495	-24%	-$30.6K	0.02%	545
2016 Q3	$136K	Buy	2,045 +1,820	+809%	+$113K	0.03%	453
2016 Q2	$12K	Hold	225	–	–	﹤0.01%	1053
2016 Q1	$12K	Sell	225 -747	-77%	-$38.8K	﹤0.01%	1017
2015 Q4	$68K	Sell	972 -920	-49%	-$62.7K	0.02%	572
2015 Q3	$118K	Buy	1,892 +14	+0.7%	+$1.1K	0.04%	420
2015 Q2	$158K	Buy	1,878 +933	+99%	+$72.6K	0.04%	406
2015 Q1	$71K	Sell	945 -1,485	-61%	-$104K	0.02%	638
2014 Q4	$151K	Sell	2,430 -3,108	-56%	-$177K	0.03%	519
2014 Q3	$288K	Sell	5,538 -1,896	-26%	-$96.7K	0.05%	363
2014 Q2	$382K	Sell	7,434 -3	-0%	-$135	0.07%	313
2014 Q1	$353K	Buy	7,437 +3,201	+76%	+$164K	0.07%	317
2013 Q4	$184K	Buy	4,236 +630	+17%	+$26.1K	0.03%	542
2013 Q3	$155K	Hold	3,606	–	–	0.02%	566
2013 Q2	$125K	Buy	+3,606	New	+$127K	0.02%	587

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

QIM

Quantitative Investment Management Charlottesville, Virginia $917M AUM 3.96% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

WFG Advisors's XBI Position: Q2 2017 in Review

WFG Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 88% in Q2 2017, selling an estimated $78K and leaving 150 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1096.

WFG Advisors first reported a position in XBI in Q2 2013 and has held it in 17 quarters since. The position peaked at $382K in Q2 2014. 314 funds tracked by Wall St. Rank hold XBI as of Q2 2017.

WFG Advisors held 150 shares of State Street SPDR S&P Biotech ETF worth $12K as of Q2 2017.
WFG Advisors sold 1,100 State Street SPDR S&P Biotech ETF shares in Q2 2017, an estimated $78K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1096 holding.
WFG Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 17 quarters since.
WFG Advisors's State Street SPDR S&P Biotech ETF position peaked at $382K in Q2 2014.
314 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.